Quote on Should investors invest in Vijaya Diagnostic IPO? by Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Below is quote on Should investors invest in Vijaya Diagnostic IPO? by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd
Based on FY2021 numbers, IPO is priced at a Price to Earnings of 64.3 times and EV/EBITDA of 30 times at the upper price band of the IPO, which is in line with the listed peer group. The company already has a higher market share in key geographi like Hyderabad and we do not expect the covid related benefit to continue in coming years. We believe that at ₹531, all the near term positives are priced in and leaves limited upside for the investors. Hence, we had assigned a “NEUTRAL” recommendation to the Vijaya Diagnostic centre limited IPO.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
